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Abstract14
Objectives: Cardiovascular function generally decreases with age, but whether this de-15
crease differs between men and women is unclear. Our aims were twofold: (i) to investigate16
age-related sex differences in left ventricular (LV) structure, function and mechanics, and17
(ii) to compare these measures between pre- and post-menopausal women in the middle-18
aged group.19
Methods: Resting echocardiography was performed in a cross-sectional sample of 8220
healthy adults (14 young men, 19 middle-aged men, 15 young women, 34 middle-aged21
women: 15 pre-menopausal and 19 post-menopausal). Two-way ANOVAs were used to22
examine sex × age interactions, and t-tests to compare pre- and post-menopausal women23
(α < 0.1).24
Results: Normalised LV mass, stroke volume and end-diastolic volume were signif-25
icantly lower in middle-aged than young men, but this difference was smaller between26
middle-aged and young women. Peak systolic apical mechanics were significantly greater27
in middle-aged men than middle-aged women, but not between young men and women.28
Post-menopausal women had significantly lower LV relaxation and mechanics (torsion,29
twisting velocity and apical circumferential strain rates) compared with middle-aged pre-30
menopausal women.31
Conclusion: Our cross-sectional findings suggest that the hearts of men and women32
may age differently, with men displaying greater differences in LV volumes accompanied33
by differences in apical mechanics.34
Introduction35
Ageing is associated with a general decline in cardiovascular function1,2. Whilst re-36
cent reviews have suggested a different pattern of age-related changes in men compared37
with women1,2, conflicting data in the literature—such as that on left ventricular (LV)38
mass and diastolic function3–11—highlight the need for more empirical evidence. Owing39
to the chronic exposure to different levels of testosterone, oestrogen, progesterone and40
epinephrine, it seems reasonable to expect that age may have a differential impact on LV41
structure and function between men and women12–14. Specifically, these hormones have42
been implicated in myocardial apoptosis7, contractility7,15–17 and stiffness18–21. The drop43
in endogenous oestrogen and progesterone concentrations following the menopause22 likely44
contributes to the reduced systolic and diastolic function23–25 observed in post-menopausal45
women, yet menopausal status has rarely been accounted for within large-scale ageing46
studies. In studies focused on comparing pre- and post-menopausal women alone, study47
groups have been limited by large age differences (e.g. a mean age difference of 24 years26),48
or by a lack of distinction between women of natural and surgically-induced menopause23.49
Accordingly, a detailed characterisation of the impact of the natural menopause on LV50
function and mechanics in a relatively age-matched cohort will help clarify the age-related51
decline in cardiac function in men and women.52
To first investigate sex differences in early cardiac ageing, we examined the interaction53
between age and sex on LV structure, function and mechanics (rotation and deformation54
of the LV base and apex) in a cross-sectional sample of young and middle-aged men and55
women. Additionally, in the middle-aged female cohort, we hypothesised that indicators56
of systolic and diastolic function, as well as measures of LV mechanics, would be lower in57
post-menopausal women.58
Methods59
Ethical approval60
All experimental procedures were approved by the Cardiff Metropolitan University’s61
School of Sport Research Ethics Committee and conformed to the ethical principles in the62
Declaration of Helsinki. Prior to the start of any experimental procedures all participants63
provided written and verbal informed consent.64
Study design65
Young adult (age 19–32 years) and middle-aged (age 45–58 years) men and women were66
recruited from the university population and the general community for a cross-sectional67
study examining the interaction of sex and age on LV structure, function and in particular,68
mechanics (15 young women, 34 middle-aged women, 14 young men, 19 middle-aged men;69
Table S1). Only non-smoking, non-diabetic (self-reported) and normotensive healthy vol-70
unteers not taking any cardiovascular or lipid-lowering medications were recruited. In ad-71
dition, to examine the impact of menopausal status on LV structure, function and mechan-72
ics, our recruitment of middle-aged women was targeted to include only distinctly pre- or73
post-menopausal women (15 pre-menopausal, 19 post-menopausal; Table S2; Figure S1);74
by design we did not recruit peri-menopausal women. The middle-aged pre-menopausal75
women were characterised as having regular menstrual cycles ranging from 21–35 days76
in length without a persistent difference of more than seven days between consecutive77
cycles22,27, and had not used oral contraceptives in the preceding four months. Post-78
menopausal women were identified by at least 12 consecutive months of amenorrhoea22,79
which had not been induced by surgery (e.g. hysterectomy). None of the post-menopausal80
women had used hormone replacement therapy (HRT) in the preceding six months.81
Aerobic capacity test82
To ensure that participants were euhydrated and well-rested before any measurements,83
they were asked to abstain from caffeine, alcohol and strenuous exercise for 24 h, and to84
drink 500 ml of water 90 min before arrival at the laboratory. Participants’ height and85
body mass (Model 770, Seca, Hamburg, Germany) were assessed (Table S1; Table S2),86
and skinfolds measured at the biceps, triceps, subscapular and suprailiac (Harpenden87
Skinfold Calliper, Baty International, West Sussex, UK) in order to estimate percentage88
body fat and fat-free mass (FFM)28,29. All participants completed a continuous ramp89
test to volitional exhaustion on an upright cycle ergometer (Corival, Lode, Groningen,90
The Netherlands) to determine peak aerobic capacity (V˙O2peak). Each test started at91
zero Watts, and the subsequent increase in intensity was individualised using age, height92
and body mass30 to achieve peak power output in approximately 10 min. Respiratory gas93
exchange (Oxycon Pro, Viasys Healthcare, Basingstoke, UK) and heart rate (RS400, Polar94
Electro, Kempele, Finland) were monitored and recorded throughout the test. Measured95
V˙O2peak was not statistically different from predicted maximal oxygen uptake
31 within96
each age-sex group (P > 0.05 with Holm-Bonferroni correction).97
Resting cardiovascular function98
Resting cardiovascular function was assessed either prior to the exercise test, or on a99
separate day. Following 10 minutes of rest, blood pressure (FinometerPRO, FMS, Fi-100
napres Measurement Systems, Arnhem, Netherlands) and echocardiographic images were101
recorded with the participant lying supine at a 30–45◦ left lateral tilt (Angio 2003, Lode,102
Groningen, Netherlands). In accordance with current guidelines, echocardiographic im-103
ages were acquired at end-expiration by the same trained sonographer21,32. Phased array104
transducers (M4S-RS, 1.5–3.6 MHz; 4V 1.7–3.3 MHz) were used on commercially avail-105
able ultrasound systems (Vivid q, GE Medical Systems, Israel Ltd, Israel; Vivid E9, GE106
Vingmed Ultrasound AS, Horten, Norway, respectively), and images were analysed oﬄine107
for LV structure, function and mechanics (EchoPAC, Version 112, GE Healthcare, Horten,108
Norway). Three consecutive cardiac cycles were analysed for each variable and the mean109
was used for statistical analyses.110
Left ventricular structure and function. Left ventricular dimensions were deter-111
mined directly from 2D parasternal long-axis images32. Left ventricular mass was esti-112
mated according to the American Society of Echocardiography recommendations32. End-113
diastolic and end-systolic volumes (EDV and ESV, respectively) were determined using114
the biplane method of discs (“modified Simpson’s rule”)32. Left ventricular length was115
calculated as the mean of the diastolic LV lengths from the biplane images. Left ventric-116
ular mass, dimensions, volumes and cardiac output were allometrically-scaled to FFM to117
enable cross-sectional comparisons independent of body size, as recommended33. A “best118
compromise” scaling exponent was calculated and applied to each measure of LV size34.119
Heart rate was determined from the ECG inherent to the ultrasound. Stroke volume120
(SV = EDV − ESV), ejection fraction ([SV/EDV] × 100), cardiac output (heart rate ×121
SV) and systemic vascular resistance (mean arterial pressure/cardiac output) were then122
calculated. Trans-mitral peak filling velocities were measured using pulsed-wave Doppler123
in the apical four-chamber view21. Isovolumic relaxation time (IVRT) and peak septal124
wall velocities at the level of the mitral annulus were assessed using pulsed-wave tissue125
Doppler imaging (TDI) in the apical four-chamber view9,21.126
Left ventricular mechanics. Left ventricular mechanics were assessed using 2D speckle127
tracking of the myocardium in the parasternal short-axis images at the LV base and apex,128
in line with previous methodology35. Circumferential strain and strain rate, rotation and129
rotational velocity at the base and apex of the LV were analysed oﬄine using commercial130
software (EchoPAC). Longitudinal strain was out of the scope of this study, as we were131
primarily interested in basal and apical mechanics17,36,37, and our group has previously132
found this measure to underestimate apical contribution35. To account for differences in133
heart rate, raw data were normalised to the percentage of systole and diastole (2D Strain134
Analysis Tool 1.0β14, Stuttgart, Germany)35. Twist and twisting velocity curves were135
calculated by subtracting time-aligned basal data from apical data, and peak values for all136
parameters were extracted from interpolated curves. Similarly, time to peak untwisting137
velocity, and to peak diastolic basal and apical rotational velocities were derived from138
interpolated curves38. Torsion was calculated as LV twist/end-diastolic LV length. Due139
to poor image quality, data on LV mechanics could not be obtained from one middle-aged140
male participant.141
Statistical analysis142
Statistical analyses were performed with R39. Reasonable normality of residuals was143
confirmed with the Shapiro-Francia test for normality and Normal quantile-quantile (Q-144
Q) plots. As Levene’s test for homogeneity of variances revealed unequal variances in145
some of our parameters, the two-way analysis of variance (ANOVA; factors: sex and age)146
with White-adjusted p-values for heteroscedasticity was used to compare all variables147
between young adult and middle-aged men and women. For variables where the sex ×148
age interaction effect was significant, Student’s t-test for independent samples was used149
post-hoc to identify differences between groups. In our secondary analysis, Student’s t-test150
for independent samples was used to compare all variables between middle-aged pre- and151
post-menopausal women, and age was added as a covariate to verify our findings. Alpha152
was set at 0.1 a priori for the best possible trade-off between false positives and negatives153
(based on power calculations40 using published data9,36,37,41–43 and the available sample154
size for this study). Data are presented as mean and standard deviation (SD) unless155
stated otherwise.156
Results157
Sex differences in left ventricular structure, function and me-158
chanics159
Left ventricular mass, wall thicknesses, volumes and cardiac output were all smaller in160
women than men (P < 0.01; Table 1). Once scaled to FFM, however, these parameters161
were no longer significantly different between the sexes (P > 0.1). Diastolic function was162
greater in women than men, as indicated by greater early diastolic velocities (E, E/A and163
E′; P < 0.1) and peak diastolic basal circumferential strain rate (P < 0.001; Table 2).164
Age-related differences in left ventricular structure, function and165
mechanics166
Left ventricular volumes, mass and cardiac output were smaller in middle-aged partic-167
ipants compared with the young adults (P < 0.05; Table 1). After normalising for168
differences in FFM, LV mass was no longer statistically different between young and169
middle-aged adults (P = 0.23), while the effect of age on LV volumes and cardiac output170
was still statistically significant (P < 0.05).171
Peak LV twist, torsion, twisting velocity, and basal and apical rotation were greater in172
middle-aged participants compared with the young adults (P < 0.1; Table 2; Figure 1).173
Diastolic function was lower in middle-aged participants, as evidenced by longer isovolumic174
relaxation times and slower early diastolic velocities (E and E′), with faster late diastolic175
velocities (A and A′) to compensate (lower E/A; all P < 0.01; Table 1). In addition,176
middle-aged participants achieved peak untwisting velocities later in the cardiac cycle,177
and had lower peak diastolic apical circumferential strain rates compared with the young178
adults (P < 0.001; Table 2; Figure 1).179
Sex differences with age in left ventricular structure, function180
and mechanics181
Normalised LV mass, SV and EDV were smaller in middle-aged than young men; but LV182
mass and SV were similar in middle-aged and young women, and the difference in EDV183
between female groups was smaller than that between male groups (P < 0.06; Table 1).184
Measures of peak systolic apical mechanics were similar in young men and women, but185
yet were all larger in middle-aged men than middle-aged women (P < 0.1; Table 2;186
Figure 1). Middle-aged men achieved peak diastolic apical and basal rotational velocities,187
and untwisting velocity later in the cardiac cycle than the young men, but this age-related188
difference was smaller in females (P < 0.05).189
Impact of menopausal status on general haemodynamics, and left190
ventricular structure, function and mechanics191
General haemodynamics and LV mass, dimensions and volumes were all similar in middle-192
aged pre- and post-menopausal women (Table 3). Normalising LV structure and volumes193
to FFM, however, revealed a greater relative LV mass, ESV and EDV in post-menopausal194
women (P < 0.1). Peak LV torsion, twisting velocity and systolic apical circumferential195
strain rate were lower in post-menopausal women compared with the pre-menopausal196
women (P < 0.1; Table 4; Figure S2). In line with their slower early diastolic myocardial197
velocity (E′; P = 0.06), post-menopausal women also had lower peak diastolic apical198
circumferential strain rates (P = 0.01). Our findings did not change when age was added199
as a covariate.200
Discussion201
In this study, we assessed LV structure, function and mechanics in a cross-sectional sample202
of young adult and middle-aged men and women. We found a greater age-related difference203
in LV mass, SV and EDV in men compared with women, coincident with greater peak204
systolic apical mechanics and later peak diastolic rotational velocities over the cardiac205
cycle in middle-aged men compared with middle-aged women. These findings suggest that206
sex differences in early cardiac ageing may be related to changes at the apex. In addition,207
we observed that post-menopausal women had impaired LV relaxation—as indicated by208
E′—and lower peak LV mechanics (torsion, twisting velocity and apical circumferential209
strain rates) compared with their middle-aged pre-menopausal counterparts. This may210
indicate an initial reduction in myocardial function after the menopause.211
Age-related differences in left ventricular structure and function212
between men and women213
We found that LV mass and SV were lower in middle-aged men than young adult men,214
but were similar in middle-aged and young adult women. In addition, EDV was lower in215
the middle-aged groups relative to the young adult groups, but this difference was greater216
among men than women. This supports previous work showing that a significant loss of217
cardiomyocytes in response to early ageing occurs only in men10. The associated lower218
EDV in middle-aged men could be underpinned, at least in part, by a greater sub-clinical219
impairment in LV relaxation in men than women with early ageing, as suggested by longer220
times to peak diastolic rotational velocities38 in our study. Although we did not measure221
hormone concentrations in this study, it is helpful to consider our findings in the context222
of previous research. It is unclear if differences in oestrogen and progesterone concen-223
trations contribute to the age-related differences in LV mass and volumes observed here,224
as these parameters have been found to be similar in pre- and post-menopausal women225
who typically experience contrasting levels of oestrogen and progesterone10,22,25. Higher226
levels of testosterone and/or epinephrine in men compared with women12,14 may how-227
ever explain the age-related differences in LV structure and volumes, as these hormones228
have been shown to stimulate apoptosis and fibrosis, which could thus decrease LV mass229
and increase LV stiffness7,18,20,21,44. Notwithstanding, it is important to acknowledge that230
our structural data conflict with a number of previous studies. Contradictory findings231
to ours—such as an age-related increase in LV mass4,6,11—may have arisen from the in-232
clusion of individuals with cardiovascular risk factors3, overlapping but different levels of233
cardiorespiratory fitness and age groups perused11, and/or different scaling methods in234
previous studies33.235
Sex differences in apical mechanics with early ageing236
Interestingly, we found that the differences in peak LV mechanics between young and237
middle-aged men compared with women were localised at the apex, with males show-238
ing a greater systolic rotation and rotational velocity. Beyond the previously discussed239
loss of functional myocytes in men, a potential explanation for these differences is their240
higher epinephrine concentrations compared with women14, which coupled with a greater241
β-adrenergic receptor density in males45 may influence LV mechanics. Epinephrine has242
been shown to exert a dominant effect on the LV apex compared with the base15, while cat-243
echolamine administration in animal studies has been shown to induce myocardial fibrosis244
especially at the apex18. We thus speculate that men may experience—sub-clinically—a245
greater sub-endocardial fibrosis46 at the apex with ageing compared with women, induced246
by higher circulating epinephrine concentrations18. If true, this could explain the higher247
peak apical rotation and rotational velocity that we observed in the middle-aged men248
compared with women due to a more dominant apical sub-epicardium36,37,47.249
Sex differences in arterial stiffness with ageing could further explain the localised250
apical differences that we observed11,48. In the Multi-Ethnic Study of Atherosclerosis251
(MESA), regression analyses detected a significant relationship between arterial stiffness252
and circumferential strain rate at the apex but not the base48. The lower peak apical253
circumferential strain and strain rate that we observed in middle-aged women in our cross-254
sectional study could thus reflect a greater increase in arterial stiffness with early ageing255
in women than men48. Whilst our measures of brachial blood pressure and calculated256
systemic vascular resistance did not indicate sex differences with age, these are poor257
surrogates for central pressure and arterial stiffness49. Future investigations focused on258
delineating age-related differences in vascular properties between men and women, and on259
the influence of differing levels of epinephrine on regional LV function would help further260
interpretation of our findings.261
Impact of the menopause on left ventricular structure, function262
and mechanics263
Given that the menopause has been associated with decreases in vascular function27, it is264
important to also consider this influence within the context of ageing studies examining265
the heart. Counter to previous reports of early concentric remodelling in women following266
the menopause25,32,50, here we observed similar LV mass, dimensions and volumes in pre-267
and post-menopausal women. This discrepancy may be due to the inclusion of women268
with surgically-induced menopause in earlier work25, and/or different cardiovascular risk269
factors and cardiorespiratory fitness levels relative to our study50. The greater relative270
LV mass that we observed in post-menopausal women may, in fact, reflect a maintenance271
of LV mass despite the known menopausal-related decline in FFM. A longitudinal study272
following middle-aged pre-menopausal women through the menopause is needed to clarify273
our findings.274
Irrespective of LV structure, and in line with previous studies23,24 and our hypothe-275
sis, our results do indicate lower LV diastolic function in post-menopausal middle-aged276
women, as evidenced by slower early diastolic wall velocity (E′). In addition, while lower277
longitudinal systolic strain and diastolic strain rate have been shown in post-menopausal278
women previously42, we have further identified lower torsion, twisting velocity and circum-279
ferential strain rates in post-menopausal women. These lower LV mechanics—albeit from280
a cross-sectional study—may reflect an initial reduction in myocardial function following281
the menopause, due to withdrawal of the positive effects of oestrogen and progesterone282
on apoptosis7, contractility7,17 and/or stiffness19. It is possible that these changes in the283
underpinning cardiac mechanics occur prior to differences in global measures of function,284
such as cardiac output or ejection fraction42. Interestingly, our findings do not indicate285
a localised effect of menopausal status on the either the LV base or apex. This suggests286
that menopausal status is unlikely to explain the age-related apical sex differences dis-287
cussed earlier, and additionally, appears to contradict the effects of oestrogen specific to288
the LV base that have been identified through animal research17. Further work is clearly289
necessary to understand cardiovascular ageing in women.290
Limitations, implications and future directions291
A limitation of this study was that circulating concentrations of catecholamines and sex292
hormones were not measured. Pre- and post-menopausal women were, however, care-293
fully recruited based on menstrual history to ensure that circulating female sex hormone294
concentrations were chronically lower in the post-menopausal group. Future work delin-295
eating the effects of cyclical variations in female sex hormone concentrations (e.g. compar-296
ing early-follicular, late-follicular and mid-luteal menstrual cycle phases) from chronically297
lower concentrations (e.g. after the menopause) would provide further insight into the298
potent effects of female sex hormones on the heart.299
Additional limitations of this study are its relatively small sample size and cross-300
sectional design. The small sample size reflects our limited resources, but also our primary301
focus on LV mechanics, which have been suggested to be more sensitive than global302
indicators of cardiac function (e.g. heart rate and cardiac output). To reduce the likelihood303
of committing a type II error due a small sample size, we set our level of statistical304
significance a priori at 0.1 and accepted the resultant trade-off between type I and type II305
errors in this study. Our findings, nonetheless, highlight mechanical differences localised to306
the apical region of the LV, which could inform future studies investigating sex differences307
with ageing. We and others have previously discussed the difficulties in separating the308
effects of the menopause from those of ageing on the female heart1,2, and the present study309
is another example of this. Despite including only middle-aged women in our secondary310
analysis, naturally post-menopausal women were, on average, six years older than the pre-311
menopausal women. Including age as a covariate, however, did not change our findings,312
and accordingly confirmed a significant impact of menopause on the LV. Notwithstanding,313
longitudinal ageing studies from young adulthood and through the menopausal transition314
will provide further insight into female cardiovascular ageing. Of particular relevance to315
women’s health in mid-life, we recommend future work into whether lifestyle interventions316
(e.g. exercise training and dietary modifications) may mitigate the decline in myocardial317
function associated with the menopause.318
Conclusions319
In conclusion, the findings of our cross-sectional study suggest that changes in LV struc-320
ture and function from young adulthood to middle-age differ between men and women:321
normalised LV mass, SV and EDV are lower in middle-aged men compared with their322
younger counterparts, but this difference is markedly less in women. Peak systolic apical323
mechanics are greater in middle-aged men than middle-aged women, but not between324
young men and women or at the base. During middle-age, post-menopausal women have325
reduced LV relaxation (as indicated by E′) and altered LV mechanics (lower peak torsion,326
twisting velocity and apical circumferential strain rates) compared with pre-menopausal327
women. Our findings provide new insight into the regional cardiac changes that may occur328
with healthy ageing, and set the foundation for future longitudinal studies investigating329
this life stage.330
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Table 1: General haemodynamics, and left ventricular (LV) structure and function in
young adult and middle-aged (older) men and women at rest.
Female Male P
Parameter Younger Older Younger Older Sex Age Sex × Age
General haemodynamics
SBP (mmHg) 114 (7) 131 (14) ‡ 121 (12) 128 (13) 0.33 <0.01 0.08
SVR (mmHg·min/L) 26.0 (4.0) 32.3 (5.2) 19.4 (5.0) 25.3 (5.5) <0.01 <0.01 0.84
Heart rate (beats/min) 57 (6) 56 (7) 54 (11) 55 (7) 0.40 0.93 0.57
Q˙ (L/min) 3.25 (0.45) 2.89 (0.45) 4.51 (1.05) 3.69 (0.79) <0.01 <0.01 0.23
Q˙ (L/min/kg0.68) 0.25 (0.03) 0.23 (0.04) 0.26 (0.06) 0.22 (0.04) 0.67 0.02 0.21
LV structure
IVSd (cm) 0.8 (0.1) 0.8 (0.1) 0.9 (0.1) 0.9 (0.1) <0.01 0.25 0.83
LVPWd (cm) 0.8 (0.1) 0.8 (0.1) 0.9 (0.1) 0.8 (0.1) <0.01 0.60 0.92
LV mass (g) 114 (24) 107 (18) 173 (30) 148 (31) <0.01 0.01 0.18
SV (mL) 58 (8) † 52 (9) †‡ 84 (12) 67 (11) ‡ <0.01 <0.01 0.02
EDV (mL) 97 (14) † 78 (13) †‡ 146 (17) 109 (15) ‡ <0.01 <0.01 0.02
ESV (mL) 39 (7) † 26 (7) †‡ 62 (8) 43 (7) ‡ <0.01 <0.01 0.08
LVLd (cm) 8.0 (0.5) 7.5 (0.7) 9.3 (0.5) 8.7 (0.5) <0.01 <0.01 0.75
Allometrically-scaled
IVSd (cm/kg0.26) 0.30 (0.03) 0.30 (0.04) 0.30 (0.02) 0.30 (0.02) 0.92 0.69 0.96
LVPWd (cm/kg0.30) 0.25 (0.03) 0.25 (0.03) 0.25 (0.03) 0.25 (0.02) 0.78 0.80 0.77
LV mass (g/kg0.90) 3.71 (0.49) 3.81 (0.66) 4.03 (0.58) 3.60 (0.53)‡ 0.70 0.23 0.05
SV (mL/kg0.74) 3.34 (0.36) † 3.27 (0.59) 3.68 (0.51) 3.06 (0.43)‡ 0.58 <0.01 0.02
EDV (mL/kg0.92) 2.89 (0.31) † 2.57 (0.45) ‡ 3.10 (0.34) 2.46 (0.31)‡ 0.56 <0.01 0.05
ESV (mL/kg1.21) 0.38 (0.05) 0.29 (0.08) 0.39 (0.05) 0.29 (0.06) 0.91 <0.01 0.81
Systolic function
Ejection fraction (%) 60 (2) † 67 (6) †‡ 57 (4) 61 (5) ‡ <0.01 <0.01 0.05
S′ (m/s) 0.07 (0.01) 0.07 (0.01) 0.08 (0.01) 0.08 (0.01) 0.02 0.52 0.51
Diastolic function
IVRT (ms) 75 (8) 92 (16) 78 (14) 93 (14) 0.59 <0.01 0.70
IVRT (%) 12 (3) 14 (3) 11 (4) 14 (3) 0.73 <0.01 0.69
E (m/s) 0.80 (0.07) 0.70 (0.13) 0.74 (0.10) 0.59 (0.10) <0.01 <0.01 0.25
E′ (m/s) 0.14 (0.02) 0.10 (0.02) 0.14 (0.02) 0.09 (0.02) 0.06 <0.01 0.40
A (m/s) 0.38 (0.07) 0.54 (0.10) ‡ 0.42 (0.08) 0.51 (0.08)‡ 0.93 <0.01 0.10
A′ (m/s) 0.07 (0.01) 0.09 (0.01) 0.07 (0.01) 0.09 (0.01) 0.17 <0.01 0.63
E/A 2.14 (0.39) 1.33 (0.27) 1.82 (0.32) 1.19 (0.26) <0.01 <0.01 0.26
SBP: systolic blood pressure. SVR: systemic vascular resistance. Q˙: cardiac output.
FFM: fat-free mass. IVSd: inter-ventricular septum thickness during diastole. LVPWd:
LV posterior wall thickness during diastole. SV: stroke volume. EDV: end-diastolic
volume. ESV: end-systolic volume. LVLd: LV length during diastole. Peak septal wall
velocity at the level of the mitral annulus during systole (S′), and early (E′) and late
diastole (A′). IVRT: isovolumic relaxation time in ms and in % diastole, where the time
at end-systole is defined as 100% and end-diastole is 200%. Peak trans-mitral filling
velocity during early (E) and late diastole (A). †P < 0.1 compared with age-matched
men. ‡P < 0.1 compared with younger counterparts. ANOVA effects with P < 0.1
(White-adjusted for heteroscedasticity) are in bold.
Table 2: Peak left ventricular (LV) mechanics during systole and diastole in young
adult and middle-aged (older) men and women at rest.
Female Male P
Parameter Younger Older Younger Older Sex Age Sex × Age
Systolic peaks
Twist (deg) 12.7 (4.0) 16.8 (4.6) 12.4 (3.3) 18.7 (5.2) 0.43 <0.01 0.31
Torsion (deg/cm) 1.6 (0.5) 2.3 (0.6) 1.3 (0.3) 2.2 (0.7) 0.16 <0.01 0.54
Twisting vel (deg/s) 85 (14) 91 (16) 91 (10) 104 (32) 0.06 0.04 0.44
LV base
Rotation (deg) -3.5 (2.5) -5.6 (3.1) -4.4 (2.1) -4.7 (2.6) 0.95 0.06 0.16
Rotational vel (deg/s) -55 (11) -49 (15) -55 (13) -45 (16) 0.51 0.01 0.65
Circ strain (%) -18 (3) -18 (4) -16 (2) -15 (3) <0.01 0.82 0.40
Circ strain rate (1/s) -1.0 (0.2) -1.0 (0.2) -1.0 (0.2) -0.9 (0.1) 0.82 0.51 0.22
LV apex
Rotation (deg) 9.7 (2.7) 11.8 (3.8) †‡ 8.7 (2.4) 14.9 (4.2) ‡ 0.18 <0.01 0.01
Rotational vel (deg/s) 56 (21) 53 (14) † 53 (16) 70 (23) ‡ 0.15 0.13 0.03
Circ strain (%) -22 (4) -20 (4) †‡ -22 (4) -24 (5) 0.12 0.67 0.10
Circ strain rate (1/s) -1.4 (0.2) -1.1 (0.2) †‡ -1.4 (0.3) -1.4 (0.3) <0.01 0.01 0.02
Diastolic peaks
Untwisting vel (deg/s) -104 (33) -93 (28) -101 (27) -91 (25) 0.70 0.13 0.94
Time to untwisting vel (%) 105 (6) 109 (7) †‡ 106 (4) 116 (8) ‡ <0.01 <0.01 0.03
LV base
Rotational vel (deg/s) 55 (20) 50 (16) 49 (22) 45 (13) 0.24 0.35 0.88
Time to rotational vel (%) 105 (7) 104 (7) † 104 (5) 111 (10) ‡ 0.17 0.10 0.03
Circ strain rate (1/s) 1.6 (0.3) 1.4 (0.4) 1.2 (0.3) 1.1 (0.3) <0.01 0.10 0.55
LV apex
Rotational vel (deg/s) -69 (29) -58 (22) -62 (22) -68 (21) 0.84 0.71 0.14
Time to rotational vel (%) 110 (8) 113 (10) † 107 (6) 120 (10) ‡ 0.33 <0.01 0.01
Circ strain rate (1/s) 2.2 (0.6) 1.6 (0.5) 2.1 (0.7) 1.7 (0.6) 0.98 <0.01 0.47
Vel: velocity. Circ: circumferential. Time to peak untwisting vel and rotational vel
in % diastole, where the time at end-systole is defined as 100% and end-diastole is
200%. †P < 0.1 compared with age-matched men. ‡P < 0.1 compared with younger
counterparts. ANOVA effects with P < 0.1 (White-adjusted for heteroscedasticity) are
in bold.
Table 3: General haemodynamics, and left ventricular (LV) structure and function in
middle-aged pre- and post-menopausal women at rest.
Middle-aged female P
Parameter Pre-menopausal Post-menopausal Menopause
General haemodynamics
Systolic blood pressure (mmHg) 128 (14) 132 (15) 0.42
SVR (mmHg·min/L) 32.3 (6.9) 32.3 (3.6) 0.99
Heart rate (beats/min) 57 (7) 55 (7) 0.63
Q˙ (L/min) 2.89 (0.57) 2.89 (0.35) 0.99
Q˙ (L/min/kg FFM0.68) 0.23 (0.04) 0.24 (0.03) 0.30
LV structure
IVSd (cm) 0.8 (0.1) 0.8 (0.1) 0.51
LVPWd (cm) 0.8 (0.1) 0.8 (0.1) 0.45
LV mass (g) 104 (17) 109 (19) 0.44
SV (mL) 52 (11) 53 (9) 0.79
EDV (mL) 76 (14) 80 (13) 0.36
ESV (mL) 24 (6) 28 (7) 0.13
LVLd (cm) 7.4 (0.5) 7.5 (0.8) 0.45
Allometrically-scaled
IVSd (cm/kg FFM0.26) 0.29 (0.04) 0.31 (0.03) 0.27
LVPWd (cm/kg FFM0.30) 0.25 (0.03) 0.25 (0.03) 0.94
LV mass (g/kg FFM0.90) 3.55 (0.50) 4.02 (0.71) 0.04
SV (mL/kg FFM0.74) 3.12 (0.60) 3.39 (0.58) 0.19
EDV (mL/kg FFM0.92) 2.38 (0.39) 2.72 (0.45) 0.03
ESV (mL/kg FFM1.21) 0.25 (0.06) 0.32 (0.07) 0.01
Systolic function
Ejection fraction (%) 68 (6) 66 (5) 0.27
S′ (m/s) 0.08 (0.01) 0.07 (0.01) 0.73
Diastolic function
IVRT (ms) 89 (17) 95 (15) 0.25
IVRT (%) 114 (3) 115 (4) 0.47
E (m/s) 0.72 (0.12) 0.68 (0.13) 0.40
E′ (m/s) 0.11 (0.02) 0.09 (0.02) 0.06
A (m/s) 0.54 (0.09) 0.54 (0.11) 0.88
A′ (m/s) 0.09 (0.02) 0.09 (0.01) 0.47
E/A 1.37 (0.28) 1.29 (0.26) 0.41
SVR: systemic vascular resistance. Q˙: cardiac output. FFM: fat-free mass. IVSd: inter-
ventricular septum thickness during diastole. LVPWd: LV posterior wall thickness
during diastole. SV: stroke volume. EDV: end-diastolic volume. ESV: end-systolic
volume. LVLd: LV length during diastole. Peak septal wall velocity at the level of
the mitral annulus during systole (S′), and early (E′) and late diastole (A′). IVRT:
isovolumic relaxation time in ms and in % diastole, where the time at end-systole is
defined as 100% and end-diastole is 200%. Peak trans-mitral filling velocity during early
(E) and late diastole (A). T-tests with P < 0.1 are in bold.
Table 4: Peak left ventricular (LV) mechanics in middle-aged pre- and post-
menopausal women at rest.
Middle-aged female P
Parameter Pre-menopausal Post-menopausal Menopause
Systolic peaks
Twist (deg) 18.1 (3.6) 15.8 (5.2) 0.15
Torsion (deg/cm) 2.5 (0.5) 2.1 (0.6) 0.07
Twisting vel (deg/s) 98 (13) 86 (17) 0.03
LV base
Rotation (deg) -6.2 (3.2) -5.1 (2.9) 0.32
Rotational vel (deg/s) -51 (16) -47 (15) 0.43
Circ strain (%) -19 (4) -17 (4) 0.33
Circ strain rate (1/s) -1.0 (0.2) -1.0 (0.2) 0.19
LV apex
Rotation (deg) 12.3 (3.6) 11.4 (4.0) 0.53
Rotational vel (deg/s) 55 (14) 51 (14) 0.39
Circ strain (%) -21 (3) -19 (4) 0.13
Circ strain rate (1/s) -1.1 (0.2) -1.0 (0.2) 0.05
Diastolic peaks
Untwisting vel (deg/s) -98 (26) -89 (29) 0.37
Time to untwisting vel (%) 108 (6) 109 (7) 0.80
LV base
Rotational vel (deg/s) 54 (14) 46 (17) 0.17
Time to rotational vel (%) 105 (5) 104 (8) 0.82
Circ strain rate (1/s) 1.5 (0.4) 1.4 (0.5) 0.58
LV apex
Rotational vel (deg/s) -60 (24) -57 (21) 0.67
Time to rotational vel (%) 114 (11) 112 (9) 0.56
Circ strain rate (1/s) 1.8 (0.6) 1.4 (0.3) 0.01
Vel: velocity. Circ: circumferential. Time to peak untwisting vel and rotational vel in
% diastole, where the time at end-systole is defined as 100% and end-diastole is 200%.
T-tests with P < 0.1 are in bold.
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Figure 1: Interpolated rotation (top) and rotational velocity (bottom) curves at the
base (blue) and apex (red), and the resultant twist/twisting velocity (black) across
the cardiac cycle. Time at end-systole is defined as 100%, and end-diastole is 200%.
AVC: aortic valve closure (solid vertical line). MVO: mitral valve opening (dashed
vertical line). • peak untwisting velocity. • peak apical rotational velocity during
diastole.
Table S1: Demographics and aerobic capacity of young adult and middle-aged (older)
men and women.
Female Male P
Parameter Younger Older Younger Older Sex Age Sex × Age
Age (years) 23 (4) 52 (4) 24 (4) 52 (4) 0.60 <0.01 0.70
Height (cm) 165.9 (5.7) 163.5 (5.8) 179.0 (6.6) 178.4 (7.8) <0.01 0.36 0.58
Body mass (kg) 65.9 (9.1) 64.0 (9.2) 81.0 (8.5) 83.2 (12.6) <0.01 0.93 0.39
Body fat (%) 30 (4) 34 (5) 17 (5) 24 (4) <0.01 <0.01 0.24
FFM (kg) 45.9 (5.8) 41.8 (5.0) 66.7 (6.6) 63.2 (8.9) <0.01 0.02 0.87
Upright peak power test
Wpeak (W) 191 (34) 146 (26) 297 (31) 254 (46) <0.01 <0.01 0.85
V˙O2peak (mL/min/kg) 36 (6) 29 (5) 44 (7) 36 (8) <0.01 <0.01 0.97
Predicted V˙O2max (mL/min/kg) 39 (3) 28 (3) 48 (2) 36 (4) <0.01 <0.01 0.53
HRmax (beats/min) 181 (8) 169 (11) 181 (5) 166 (9) 0.47 <0.01 0.47
Test duration (min) 8.45 (1.16) 8.11 (1.21) 8.64 (0.75) 8.83 (1.14) 0.08 0.77 0.30
Values are in mean (SD). FFM: fat-free mass. Wpeak: Peak power output.
V˙O2peak: Peak oxygen uptake. Predicted V˙O2max: Maximal oxygen uptake predicted
using the FRIEND equation31. HRmax: Maximum heart rate. ANOVA effects with
P < 0.1 (White-adjusted for heteroscedasticity) are in bold.
Table S2: Demographics and aerobic capacity of middle-aged pre- and post-
menopausal women.
Middle-aged female P
Parameter Pre-menopausal Post-menopausal Menopause
Height (cm) 162.3 (6.8) 164.5 (4.8) 0.27
Body mass (kg) 65.3 (10.5) 63.0 (8.3) 0.49
Body fat (%) 32 (4) 36 (5) 0.03
FFM (kg) 43.8 (5.9) 40.1 (3.4) 0.03
Upright peak power test
Wpeak (W) 150 (27) 142 (25) 0.40
V˙O2peak (mL/min/kg) 29 (4) 29 (5) 0.74
Predicted V˙O2max (mL/min/kg) 29 (3) 27 (3) 0.10
HRmax (beats/min) 169 (10) 168 (11) 0.70
Test duration (min) 8.17 (1.11) 8.07 (1.32) 0.81
FFM: fat-free mass. Wpeak: Peak power output. V˙O2peak: Peak oxygen uptake. Pre-
dicted V˙O2max: Maximal oxygen uptake predicted using the FRIEND equation
31.
HRmax: Maximum heart rate. T-tests with P < 0.1 are in bold.
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Figure S1: Age distribution of pre- (Pre-M) and post-menopausal (Post-M) women.
—– Mean and  standard deviation within each group.
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Figure S2: Interpolated rotation (top) and rotational velocity (bottom) curves at
the base (blue) and apex (red), and the resultant twist/twisting velocity (black) across
the cardiac cycle in middle-aged pre- (solid lines) and post-menopausal (dashed lines)
women. Time at end-systole is defined as 100%, and end-diastole is 200%. Peak twisting
velocity in • pre-menopausal and ◦ post-menopausal women. AVC: aortic valve closure
(solid black vertical line). MVO: mitral valve opening (green vertical line).
